Prism Ideas, an independent global provider of medical communications and drug development consultancy services, today announced that Dr. James Sawyer, CEO, has been selected by PharmaVOICE magazine as one of the 100 most inspirational and influential people in the pharmaceutical industry. James has been recognised for his role in founding Prism Ideas and his sustained contribution to the advancement of pharmaceutical research, which has greatly enhanced the management and treatment options for debilitating illnesses. The PharmaVOICE 100 winners are nominated by the magazine’s readers based on the individual’s ability to inspire and positively impact on corporate leadership, research and development in the pharmaceutical industry.
“I am surprised and delighted to have been nominated to receive this prestigious award and to be listed alongside the other recipients,” James said,“At Prism Ideas we believe in putting patients and people first. The recognition represented by this award would not have been possible had I not been able to work with such innovative and pioneering individuals who share my vision of developing new strategies that advance processes within the industry to improve healthcare delivery.”
For almost 20 years, James has dedicated his efforts to the clinical application of pharmaceutical industry research. During his career, James has served the life sciences through a number of different roles, including clinical positions in general medicine and anaesthetics as well as in pharmaceutical clinical research. His experience as a specialist pharmaceutical physician spans all phases of clinical research and has resulted in more than 50 publications across a variety of therapeutic areas including migraine, bone metabolism, asthma and HIV.
As a leader in his field, James truly has a global vision that underpins the success he has driven in his early career and since forming Prism Ideas. The company provides its clients with a broad range of services from clinical program consultancy and clinical trial support to medical communications. Its team is committed to developing a unique range of services that deliver real improvements to how pharmaceutical companies manage their drug development processes and the commercialisation of new therapies. Over the past 10 years, James has led Prism Ideas through an exceptional growth period, which has seen it expand into overseas markets including Switzerland and the U.S.
Nigel Brooksby, non-executive chairman, Prism Ideas, comments: “Throughout his career, James has demonstrated an ability to apply exceptional talent in pharmaceutical medicine across diverse subjects and therapy areas. Always at the forefront of innovation, he has led Prism Ideas to become a pharmaceutical medicine consultancy operating at a global level.” Nigel continues,“James possesses a rare combination of exceptional business acumen and whole-hearted devotion to medical science. I have worked with many physicians and have found his entrepreneurial skills and thorough understanding of the medical profession to be unique.”
For further information about Prism Ideas, please call +44 (0) 1270 621 724 or visit prismideas.com/.
About Prism Ideas
Prism Ideas (prismideas.com) is an independent company providing drug development consultancy and expert medical affairs support to the pharmaceutical industry. The company offers a full range of medical communications services including congress materials, journal articles, publication plans, advisory boards and advocacy development; drug development consultancy and expert medical support throughout the clinical evaluation drugs from medical monitoring of early stage clinical studies through to post-marketing activities.
Prism’s knowledge of industry, together with a thorough understanding of the science, ensures that clinical trials and medical communications maintain the highest scientific quality whilst meeting the needs of the pharmaceutical industry.
Prism currently has offices in the UK, Switzerland and the U.S.